| API Access | |

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure from TMS Co.,Ltd. was processed by Pulse News Wire on March 30, 2026. It represents a primary source document for Japanese Dividends sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

TMS Outlines Growth Strategy Through Pipeline Development and Financing Initiatives

TOKYO, Mar 30 (Pulse News Wire) – TMS CO.,LTD. (4891.T) outlined its growth strategy centered around clinical development pipelines, particularly focusing on compounds such as TMS-007 and TMS-008. TMS

View all TMS Co.,Ltd. disclosures →